Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Newcastle Disease Virus /von 2019-04-29 / Int. J. Cancer 2019 10;145(7):1958-1969Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia
/in Acute Leukemia, Dendritic Cells, International Publications /von 2019-04-27 / J Clin Med 2019 Apr;8(5)A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2019-04-27 / Trials 2019 Apr;20(1):242Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals
/in Dendritic Cells, HIV/AIDS, International Publications /von 2019-04-24 / Front Immunol 2019;10:874A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials
/in Dendritic Cells, Glioblastoma, International Publications /von 2019-04-15 / Cancers (Basel) 2019 Apr;11(4)Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2019-04-11 / Front Immunol 2019;10:766Immunotherapy in Ovarian Cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2019-04-05 / Surg. Oncol. Clin. N. Am. 2019 Jul;28(3):447-464New treatment modalities with vaccine therapy in renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International Publications /von 2019-04-01 / Urol Ann 2019 Apr-Jun;11(2):119-125Melanoma vaccines: clinical status and immune endpoints
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2019-04-01 / Melanoma Res. 2019 04;29(2):109-118IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de